Targeted disruption of the EZH2–EED complex inhibits EZH2-dependent cancer [PDF]
Enhancer of zeste homolog 2 (EZH2) is the histone lysine N-methyltransferase component of the Polycomb repressive complex 2 (PRC2), which, in conjunction with embryonic ectoderm development (EED) and suppressor of zeste 12 homolog, regulates cell lineage determination and homeostasis.
Kim, Woojin +6 more
openaire +4 more sources
Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height [PDF]
The biological processes controlling human growth are diverse, complex and poorly understood. Genetic factors are important and human height has been shown to be a highly polygenic trait to which common and rare genetic variation contributes.
Tatton-Brown, Katrina +57 more
core +1 more source
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma [PDF]
Background: The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with
Johannes Hüsing +29 more
core +2 more sources
EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains [PDF]
Chromatin is organized into topologically associating domains (TADs) enriched in distinct histone marks. In cancer, gain-of-function mutations in the gene encoding the enhancer of zeste homolog 2 protein (EZH2) lead to a genome-wide increase in histone-3
Marco Mina +50 more
core +2 more sources
Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells [PDF]
Differentiation of human endometrial stromal cells (HESC) into decidual cells represents a highly coordinated process essential for embryo implantation. We show that decidualizing HESC down-regulate the histone methyltransferase enhancer of Zeste homolog
Poutanen, Matti +14 more
core +1 more source
EZH2: a pleiotropic protein [PDF]
In this issue of Blood , [Yan et al][1] report their findings in natural killer/T-cell lymphoma (NKTL) and present experimental evidence that EZH2 can act as a transcriptional activator, independent of its methyltransferase activity, when phosphorylated by JAK3.
openaire +2 more sources
Ezh2-mediated epigenetic silencing may influence expression of exhaustion-associated molecules.
(A) Experimental setup. Control CD45.1+ (wild-type, WT) and Ezh2-heterozygous CD45.1.2+(Ezh2fl/wtCd4Cre+, Ezh2 HET) CD8+ P14 T cells were cotransferred into congenically distinct CD45.2+ recipient mice prior to infection with LCMV-Cl13; recipient mice ...
Lara Labarta-Bajo (9096773) +14 more
core +1 more source
EZH2: Not EZHY (Easy) to Deal [PDF]
Abstract Seminal discoveries have established that epigenetic modifications are important for driving tumor progression. Polycomb group (PcG) proteins are highly conserved epigenetic effectors that maintain, by posttranslational modification of histones, the silenced state of genes involved in critical biologic processes, including ...
Gauri, Deb +2 more
openaire +2 more sources
Endometrial cancer (EC) is one of the most common gynaecological tumours in the worldwide. Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) promotes cell proliferation, migration and invasion in EC cells. However, the molecular
Wang Wei +6 more
doaj +1 more source
EZH2: An Accomplice of Gastric Cancer
Gastric cancer is the fifth most common cancer and the third leading cause of cancer deaths worldwide. Understanding the factors influencing the therapeutic effects in gastric cancer patients and the molecular mechanism behind gastric cancer is still facing challenges.
Yu, Wuhan +8 more
openaire +2 more sources

